Patent · US Active

Methods and compositions using FGF23 fusion polypeptides

US8420088B2 · kind B2 · utility

41Cited by

7References

18Claims

0Family size

Assignee

Novartis AG · CH

Inventors

David Glass · Cambridge, US
Shou-Ih Hu · Cambridge, US

Key dates

Filing date	Jan 29, 2010
Grant date	Apr 16, 2013
Priority date	—
Expiry date	Jan 29, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/32
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to fusion polypeptides comprising Klotho protein or an active fragment thereof and FGF23 or an active fragment thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.